Prairiewood Capital, LLC Vanda Pharmaceuticals Inc. Transaction History

Prairiewood Capital, LLC

  • $233 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022
BUY
$10.84 - $16.55 $380,343 - $580,689
35,087 Added 232.7%
50,165 $567,000
Q2 2021

Jul 13, 2021
SELL
$15.71 - $21.51 $152,559 - $208,883
-9,711 Reduced 39.17%
15,078 $324,000
Q1 2021

Apr 13, 2021
SELL
$13.42 - $20.28 $476,074 - $719,433
-35,475 Reduced 58.87%
24,789 $372,000
Q4 2020

Jan 15, 2021
BUY
$9.77 - $13.81 $588,779 - $832,245
60,264 New
60,264 $792,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $247M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Prairiewood Capital, LLC Portfolio

Follow Prairiewood Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairiewood Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairiewood Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email